Who owns LYRA THERAPEUTICS INC?
- Ticker: LYRA
- CUSIP Number: 55234l105
Tip: Access positions for across all investors
Analyze quarterly positions in Lyra Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lyra Therapeutics stock
Who bought or sold LYRA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Perceptive Advisors | 13M | $2.6M | 0% | Dec 2024 |
|
| BlackRock | 3.1M | $642k | 4% | Dec 2024 |
|
| Samsara BioCapital | 2.0M | $406k | -29% | Dec 2024 |
|
| Vanguard Group | 1.8M | $368k | 0% | Dec 2024 |
|
| Ikarian Capital | 1.1M | $218k | 0% | Dec 2024 |
|
| Geode Capital Management | 886k | $183k | 15% | Dec 2024 |
|
| Goldman Sachs Group | 556k | $115k | 1% | Dec 2024 |
|
| State Street Corporation | 489k | $101k | 0% | Dec 2024 |
|
| UBS Group | 425k | $88k | 1606% | Dec 2024 |
|
| Two Sigma Advisers | 386k | $80k | -16% | Dec 2024 |
|
| Qube Research & Technologies | 342k | $71k | 100% | Dec 2024 |
|
| Northern Trust | 286k | $59k | 56% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 245k | $51k | 100% | Dec 2024 |
|
| Boothbay Fund Management | 234k | $48k | 1% | Dec 2024 |
|
| Morgan Stanley | 217k | $45k | -67% | Dec 2024 |
|
| Two Sigma Investments | 210k | $43k | -26% | Dec 2024 |
|
| Jpmorgan Chase & Co | 156k | $32k | 162% | Dec 2024 |
|
| New York State Common Retirement Fund | 155k | $32k | 0% | Dec 2024 |
|
| Charles Schwab Investment Management | 112k | $23k | 0% | Dec 2024 |
|
| Susquehanna International | 103k | $21k | 701% | Dec 2024 |
|
| FMR | 100k | $21k | 148% | Dec 2024 |
|
| Sei Investments | 84k | $17k | -92% | Dec 2024 |
|
| Bank of New York Mellon | 76k | $16k | 0% | Dec 2024 |
|
| Barclays | 75k | $16k | 19% | Dec 2024 |
|
| Bank Of Montreal | 54k | $11k | -55% | Dec 2024 |
|
| Bank of America Corporation | 53k | $11k | 7% | Dec 2024 |
|
| Virtu Financial | 42k | $9.0k | 100% | Dec 2024 |
|
| Rhumbline Advisers | 41k | $8.5k | 0% | Dec 2024 |
|
| Tower Research Capital | 40k | $8.2k | 163% | Dec 2024 |
|
| Citigroup | 38k | $7.9k | 9% | Dec 2024 |
|
| Alliancebernstein | 33k | $6.8k | 0% | Dec 2024 |
|
| SG Americas Securities | 32k | $7.0k | -12% | Dec 2024 |
|
| AQR Capital Management | 29k | $5.9k | -47% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 27k | $6.8k | 100% | Sep 2024 |
|
| Wells Fargo & Company | 25k | $5.1k | 41% | Dec 2024 |
|
| Corebridge Financial | 24k | $5.0k | 100% | Dec 2024 |
|
| Invesco | 24k | $4.9k | 4% | Dec 2024 |
|
| Citadel Advisors | 21k | $4.3k | -100% | Dec 2024 |
|
| Abel Hall | 18k | $3.6k | 100% | Dec 2024 |
|
| T. Rowe Price Associates | 18k | $4.0k | 0% | Dec 2024 |
|
| ProShare Advisors | 14k | $2.8k | 100% | Dec 2024 |
|
| Diversified | 12k | $3.1k | 100% | Sep 2024 |
|
| CWM | 5.4k | $1.0k | 629% | Dec 2024 |
|
| Royal Bank of Canada | 5.3k | $2.2k | -14% | Dec 2024 |
|
| Summit Investment Advisors | 4.7k | $979.016500 | 0% | Dec 2024 |
|
| SBI Securities | 4.3k | $881.121600 | 100% | Dec 2024 |
|
| National Bank Of Canada /fi/ | 3.7k | $950.900000 | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 3.5k | $723.844800 | 0% | Dec 2024 |
|
| Amalgamated Bank | 1.7k | $0 | 0% | Dec 2024 |
|
| Brian McDonald | 1.2k | $238.985800 | 0% | Dec 2024 |
|
| Bryn Mawr Trust | 1.0k | $211.970000 | 0% | Dec 2024 |
|
| Advisor Group Holdings | 878.00 | $228.016600 | -36% | Dec 2024 |
|
| NISA Investment Advisors | 500.00 | $103.000000 | 1251% | Dec 2024 |
|
| Jones Financial Companies, L.L | 500.00 | $103.000000 | 0% | Dec 2024 |
|
| Simplex Trading | 363.00 | $0 | -91% | Dec 2024 |
|
| EverSource Wealth Advisors | 119.00 | $25.001900 | 100% | Dec 2024 |
|
| Sterling Capital Management | 88.00 | $17.996000 | 0% | Dec 2024 |
|
Who sold out of Lyra Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Everhart Financial Group | Sep 2024 | 253k | $65k |
| ExodusPoint Capital Management | Sep 2024 | 159k | $41k |
| Acadian Asset Management | Sep 2024 | 111k | $28k |
| Beacon Pointe Advisors | Sep 2024 | 77k | $20k |
| Jane Street | Sep 2024 | 55k | $14k |
| XTX Topco | Sep 2024 | 18k | $4.6k |
| DLK Investment Management | Sep 2024 | 12k | $3.1k |
| Geneos Wealth Management | Sep 2024 | 3.5k | $919.880000 |
| Capital Performance Advisors | Sep 2024 | 533.00 | $136.981000 |